Biophage Pharma Inc.
|
|||
| Mailing Address: | 6100 Royalmount Montreal, Québec H4P 2R2 |
Head Office Address: | 6100 Royalmount Montreal, Québec H4P 2R2 |
| Contact Name: | Rosemonde Mandeville | Principal Regulator: | Quebec |
| Business e-mail address: | rosemonde.mandeville@biophagepharma.net | Short Form Prospectus Issuer: | No |
| Telephone Number: | 514 496-1452 | Reporting Jurisdictions: | British Columbia, Alberta, Quebec |
| Fax Number: | 514 496-1521 | Stock Exchange: | TSX Venture |
| Date of Formation: | May 4 2000 | Stock Symbol: | BUG |
| Jurisdiction Where Formed: | Canada | Auditor: | Raymond Chabot Grant Thornton LLP |
| Industry Classification: | other | General Partner: | |
| CUSIP Number: | 04064P | Transfer Agent: | CIBC Mellon Trust Co. |
| Financial Year-End: | Nov 30 | Size of Issuer (Assets): | Under $5,000,000 |
|
